Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Suit against TPL

2010-04-09

PTSC's 10-Q also reports that during the February quarter the Company reaffirmed its commitment to the MMP(TM) portfolio of microprocessor patents by providing two loans totaling $1,950,000 to TPL. One of the loans issued currently is in default causing the Company to take a charge to earnings of $1,000,000 plus interest in the event of its non-collection, while at the same time the Company has asserted certain offsets to amounts claimed to be due TPL but are otherwise in dispute. The Company is working aggressively to resolve this issue and to provide for the resumption of productive license activity from the MMP(TM) portfolio

To provide for the resumption of productive license activity would seem to imply that license activity has completely stopped. For if we don’t have productive license activity what do we have? We filed suit against TPL after this press release. According to the Court Calendar (Santa Clara) there is nothing scheduled before July 1 and a case management conf scheduled for 9/14 (case # 110CV169836).

Does this mean that we should expect absolutely no license activity before the case is over? Which means, even if the USPTO came out with a positive decision on Monday, we should still expect no license activity? Is this non activity also a breach of the commercialization agreement? Could that mean yet another suit against TPL

Anybody

9
Jun 12, 2010 07:01PM
4
Jun 13, 2010 06:25PM
Share
New Message
Please login to post a reply